8 резултата
FIELD OF THE INVENTION
The present invention is related to the use of oxindole hydrazide derivatives of formula (I) for the treatment and/or prevention of metabolic disorders mediated by insulin resistance or hyperglycemia, comprising diabetes type I and/or II, inadequate glucose tolerance, insulin
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates to substituted carboxylic acids and more specifically to such compounds that are useful in the treatment of diabetes. More specifically, it relates to such compounds that are capable of inhibiting Protein tyrosine
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates to substituted carboxylic acids and more specifically to such compounds that are useful in the treatment of syndrome X (consisting of such abnormalities as obesity, dyslipidemia, hypercoagulation, hypertension, insulin
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates to phenyl substituted carboxylic acids and more specifically to such compounds that are useful in the treatment of syndrome X (consisting of such abnormalities as obesity, dyslipidemia, hypercoagulation, hypertension,
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates to phenyl substituted carboxylic acids and more specifically to such compounds that are useful in the treatment of syndrome X (consisting of such abnormalities as obesity, dyslipidemia, hypercoagulation, hypertension,
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates to substituted carboxylic acids and more specifically to such compounds that are useful in the treatment of syndrome X (consisting of such abnormalities as obesity, dyslipidemia, hypercoagulation, hypertension, insulin
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates to heterocyclic substituted carboxylic acids and more specifically to such compounds that are useful in the treatment of syndrome X (consisting of such abnormalities as obesity, dyslipidemia, hypercoagulation, hypertension,
FIELD OF THE INVENTION
The present invention relates to methods for screening compounds to determine if such compounds are capable of enhancing islet cell activity and/or survival, capable of promoting CREB-mediated gene expression in islet cells, capable of effecting transport of Transducers of